HYDROXYZINE PAMOATE
- Product NDC
- 60760-169
- 11-digit product format
- 607600169
- Labeler code
- 60760
- Product ID
- 60760-169_7ad086e3-91fc-fcb7-e053-2a91aa0acdfe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYDROXYZINE PAMOATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA201507
- Marketing category
- ANDA
- Marketing start
- 2018-02-22
- Marketing end
- 0000-00-00
- Substance
- HYDROXYZINE PAMOATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC],Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| M20215MUFR | HYDROXYZINE PAMOATE | 10246-75-0 | HYDROXYZINE PAMOATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-169-30 | 60760016930 | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-169-30) | 30 capsule | 2018-02-22 | 0000-00-00 | No | No | Current |